FR
Contact
EquipeExpertise
ActualitésClassements & distinctionsPublications & conférences
À propos de nousCarrièreContact
de|fr|it|en
DEITEN
Contact
EquipeExpertise
ActualitésClassements & distinctionsPublications & conférences
À propos de nousCarrièreContact
de|fr|it|en
DEITEN
de|fr|it|en
Bâle Berne Binningen China Desk Genève Gstaad Japan Desk Lausanne Lugano Sion ZurichBâle Berne Binningen China Desk Genève Gstaad Japan Desk Lausanne Lugano Sion Zurich
  • Equipe
  • Expertise
  • Actualités
  • Classements & distinctions
  • Publications & conférences
  • À propos de nous
  • Carrière
  • Contact
  • LinkedIn
  • Instagram
Imprint–Terms of use–Privacy notice–Cookie policy–
© 2026
  • Equipe
  • Expertise
  • Actualités
  • Classements & distinctions
  • Publications & conférences
  • À propos de nous
  • Carrière
  • Contact
  • LinkedIn
  • Instagram
Imprint–Terms of use–Privacy notice–Cookie policy–
© 2026

Transactions & cas

Marco Sibold
  • Kellerhals Carrard advises eps Holding GmbH on the combination of the eps Event Group and NÜSSLI (Switzerland) Ltd.Kellerhals Carrard advises eps Holding GmbH on the combination of the eps Event Group and NÜSSLI (Switzerland) Ltd.27 août 2026
  • Kellerhals Carrard berät Eigentümer der Tretor AG bei Transaktion mit Pictet Alternative AdvisorsKellerhals Carrard berät Eigentümer der Tretor AG bei Transaktion mit Pictet Alternative Advisors11 mars 2026
  • Deal Ticker: Kellerhals Carrard advised Sofinnova Partners and Earlybird Venture Capital on financing round with HAYA TherapeuticsDeal Ticker: Kellerhals Carrard advised Sofinnova Partners and Earlybird Venture Capital on financing round with HAYA Therapeutics15 mai 2025
  • Deal Ticker: Kellerhals Carrard Advised MoonLake Immunotherapeutics on Debt Financing with Hercules Capital, Inc.Deal Ticker: Kellerhals Carrard Advised MoonLake Immunotherapeutics on Debt Financing with Hercules Capital, Inc.4 avril 2025
  • Deal Ticker: Kellerhals Carrard berät Orell Füssli bei der Übernahme der Verlag SKV AGDeal Ticker: Kellerhals Carrard berät Orell Füssli bei der Übernahme der Verlag SKV AG13 mars 2025
  • Kellerhals Carrard Advises on the Sale of Baccinex S.A. to Adragos PharmaKellerhals Carrard Advises on the Sale of Baccinex S.A. to Adragos Pharma3 décembre 2024
  • Deal Ticker: Kellerhals Carrard Advises Rhenopharma Group in Acquisition of Konapharma AGDeal Ticker: Kellerhals Carrard Advises Rhenopharma Group in Acquisition of Konapharma AG28 juin 2024
  • Deal Ticker: Kellerhals Carrard Advised on Acquisition of Majority Stake in Walter Meier (Fertigungslösungen) AGDeal Ticker: Kellerhals Carrard Advised on Acquisition of Majority Stake in Walter Meier (Fertigungslösungen) AG27 mai 2024
  • Deal Ticker: Kellerhals Carrard advised Aitonomi in intensified strategic partnership by JOSTDeal Ticker: Kellerhals Carrard advised Aitonomi in intensified strategic partnership by JOST22 mai 2024
  • Deal Ticker: Novartis hands over the Life-Science-Park Rhine Valley to GETEC Switzerland.Deal Ticker: Novartis hands over the Life-Science-Park Rhine Valley to GETEC Switzerland.23 août 2023
  • Deal Ticker: Kellerhals Carrard advised palero on the acquisition of Fischer Söhne AGDeal Ticker: Kellerhals Carrard advised palero on the acquisition of Fischer Söhne AG9 août 2023
  • Deal Ticker: Kellerhals Carrard advised on sale of Franz Carl WeberDeal Ticker: Kellerhals Carrard advised on sale of Franz Carl Weber5 juillet 2023